loading

Clearmind Medicine Inc Borsa (CMND) Ultime notizie

pulisher
11:20 AM

Clearmind Medicine completes second cohort enrollment in Phase I/IIa AUD trial - TipRanks

11:20 AM
pulisher
10:07 AM

Clearmind Medicine announces successful completion of second cohort enrollment - marketscreener.com

10:07 AM
pulisher
09:37 AM

Clearmind completes enrollment for second AUD treatment trial cohort - Investing.com

09:37 AM
pulisher
09:29 AM

Clearmind completes enrollment for second AUD treatment trial cohort By Investing.com - Investing.com South Africa

09:29 AM
pulisher
08:51 AM

Clearmind Medicine Inc. Announces Successful Enrollment of Second Patient Cohort in Phase I/IIa Trial for CMND-100 to Treat Alcohol Use Disorder - Quiver Quantitative

08:51 AM
pulisher
08:45 AM

Clearmind Medicine (Nasdaq: CMND) fills 2nd CMND-100 AUD trial cohort - Stock Titan

08:45 AM
pulisher
Dec 15, 2025

Clearmind Medicine announces receipt of Nasdaq minimum bid price notification - MSN

Dec 15, 2025
pulisher
Dec 15, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Dec 15, 2025
pulisher
Dec 12, 2025

Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment - The Manila Times

Dec 12, 2025
pulisher
Dec 12, 2025

Clearmind Medicine Regains Compliance With Nasdaq's Minimum Stockholders' Equity Requirement - marketscreener.com

Dec 12, 2025
pulisher
Dec 12, 2025

Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - The Manila Times

Dec 12, 2025
pulisher
Dec 12, 2025

Clearmind Medicine regains compliance with Nasdaq listing rule By Investing.com - Investing.com Canada

Dec 12, 2025
pulisher
Dec 12, 2025

Clearmind regains compliance with Nasdaq minimum equity rule - Investing.com

Dec 12, 2025
pulisher
Dec 12, 2025

Clearmind Medicine Inc. Regains Compliance with Nasdaq Listing Rule on Minimum Stockholders’ Equity - Quiver Quantitative

Dec 12, 2025
pulisher
Dec 12, 2025

Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum ... | Associated Press | syndication news - Enidnews.com

Dec 12, 2025
pulisher
Dec 11, 2025

Clearmind Medicine To Implement 1-for-40 Reverse Stock Split Next Week - Nasdaq

Dec 11, 2025
pulisher
Dec 11, 2025

Why Did Clearmind Medicine Shares Plunge 29% After Hours? - Benzinga

Dec 11, 2025
pulisher
Dec 10, 2025

Clearmind Medicine to enact 1-for-40 reverse share split; shares down - MSN

Dec 10, 2025
pulisher
Dec 10, 2025

Clearmind Medicine to implement 1-for-40 reverse stock split By Investing.com - Investing.com Australia

Dec 10, 2025
pulisher
Dec 10, 2025

Clearmind Medicine to implement 1-for-40 reverse stock split - Investing.com

Dec 10, 2025
pulisher
Dec 10, 2025

Clearmind Medicine Inc. Announces 1-for-40 Reverse Share Split to Regain Nasdaq Compliance - Quiver Quantitative

Dec 10, 2025
pulisher
Dec 10, 2025

Clearmind Medicine Announces 1-for-40 Reverse Share Split - The Manila Times

Dec 10, 2025
pulisher
Dec 10, 2025

Clearmind Medicine Announces 1-for-40 Reverse Share Split | Associated Press | syndication news - Enidnews.com

Dec 10, 2025
pulisher
Dec 09, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Dec 09, 2025
pulisher
Dec 08, 2025

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification - marketscreener.com

Dec 08, 2025
pulisher
Dec 07, 2025

Clearmind Medicine Shares Surge After Securing Final Approval for AUD Drug Trial Site - MSN

Dec 07, 2025
pulisher
Dec 05, 2025

Clearmind Medicine reports regaining Nasdaq equity compliance after financings - Investing.com

Dec 05, 2025
pulisher
Dec 05, 2025

Clearmind Medicine reports regaining Nasdaq equity compliance after financings By Investing.com - Investing.com Australia

Dec 05, 2025
pulisher
Dec 05, 2025

Clearmind Medicine Inc. Receives Nasdaq Compliance Notice Regarding Minimum Bid Price Requirement - Quiver Quantitative

Dec 05, 2025
pulisher
Dec 05, 2025

Clearmind Medicine stock drops after Nasdaq compliance notice By Investing.com - Investing.com South Africa

Dec 05, 2025
pulisher
Dec 05, 2025

Clearmind Medicine stock drops after Nasdaq compliance notice - Investing.com

Dec 05, 2025
pulisher
Dec 04, 2025

Is Clearmind Medicine Inc. stock near bottom after declineWeekly Loss Report & High Return Stock Watch Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Clearmind Medicine Inc. stock outperform tech sector in 2025July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How Clearmind Medicine Inc. (CWY0) stock behaves under inflation pressureWeekly Gains Report & Low Risk Entry Point Tips - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Clearmind Medicine Inc files for offering of up to 16 million common sharesSEC filing - marketscreener.com

Dec 03, 2025
pulisher
Dec 03, 2025

What MACD trends signal for Clearmind Medicine Inc. (CWY0) stock - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Is Clearmind Medicine Inc. (CWY0) stock a good hedge against inflationJuly 2025 Levels & Risk Managed Investment Signals - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Can Clearmind Medicine Inc. (CWY0) stock double in coming yearsJuly 2025 Earnings & Verified High Yield Trade Plans - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Clearmind enrolls first participant in AUD trial at Hadassah Medical - Investing.com India

Dec 02, 2025
pulisher
Dec 02, 2025

Clearmind enrolls first participant in AUD trial at Hadassah Medical By Investing.com - Investing.com Canada

Dec 02, 2025
pulisher
Dec 02, 2025

Clearmind Medicine advances CMND-100 to dosing phase at Hadassah Medical Center - marketscreener.com

Dec 02, 2025
pulisher
Dec 02, 2025

Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder - The Manila Times

Dec 02, 2025
pulisher
Dec 02, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Dec 02, 2025
pulisher
Dec 01, 2025

Clearmind Medicine (CMND) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Dec 01, 2025

Clearmind reports positive results in alcohol disorder treatment trial By Investing.com - Investing.com Nigeria

Dec 01, 2025
$38.53
price up icon 0.42%
$98.38
price down icon 0.32%
$31.57
price up icon 0.83%
$93.57
price down icon 0.31%
biotechnology ONC
$300.09
price down icon 5.87%
$196.92
price down icon 1.22%
Capitalizzazione:     |  Volume (24 ore):